Search

Author/Creator Berry, Neil

1. Chemical modification of the 6'‐amino cyclopropyl of abacavir eliminates HLA‐B*57:01‐restricted CD8+ T‐cell activation without loss of antiviral activity. (18th July 2014)

Authors:
Alhaidari, Mohammad; Yang, Emma; Berry, Neil; Owen, Andrew; Clarke, Steve; O'Neill, Paul; Naisbitt, Dean; Park, Kevin
Journal:
Clinical and translational allergy
Issue:
Volume 4:(2014)supplement 3
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Appropriate referral and selection of patients with chronic pain for spinal cord stimulation: European consensus recommendations and e‐health tool. (4th April 2020)

Authors:
Thomson, Simon; Huygen, Frank; Prangnell, Simon; De Andrés, José; Baranidharan, Ganesan; Belaïd, Hayat; Berry, Neil; Billet, Bart; Cooil, Jan; De Carolis, Giuliano; Demartini, Laura; Eldabe, Sam; Gatzinsky, Kliment; Kallewaard, Jan W.; Meier, Kaare; Paroli, Mery; Stark, Angela; Winkelmüller, Matt...
Journal:
European journal of pain
Issue:
Volume 24:Number 6(2020)
Page Start:
1169
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Modification of the cyclopropyl moiety of abacavir provides insight into the structure activity relationship between HLA‐B*57:01 binding and T‐cell activation. Issue 3 (9th October 2019)

Authors:
Thomson, Paul J.; Illing, Patricia T.; Farrell, John; Alhaidari, Mohammad; Bell, Catherine C.; Berry, Neil; O'Neill, Paul M.; Purcell, Anthony W.; Park, Kevin B.; Naisbitt, Dean J.
Journal:
Allergy
Issue:
Volume 75:Issue 3(2020)
Page Start:
636
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗